Takayoshi Tachibana1, Yuho Najima2, Yu Akahoshi3, Shigeki Hirabayashi4, Kaito Harada5, Kazuteru Ohashi2, Naoyuki Uchida6, Takahiro Fukuda7, Masashi Sawa8, Masao Ogata9, Junji Tanaka10, Tatsuo Ichinohe11, Yoshiko Atsuta12, Shinichi Kako3 (1.Dep. of Hematology, Kanagawa Cancer Center, Yokohama, Japan, 2.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Saitama Medical Center, Jichi Medical University, Saitama, Japan, 4.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 5.Department of Hematology and Oncology, Tokai University, Isehara, Japan, 6.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 7.National Cancer Center Hospital, Tokyo, Japan, 8.Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan, 9.Department of Hematology, Oita University Hospital, Oita, Japan, 10.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 11.Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan, 12.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)
Session information
Oral Session
Oral Session 2-12D Ph+ALL
Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.12 (Tokyo International Forum, 5F G510)
Chair: Nobuaki Dobashi (Division of Clinical Oncology and Hematology, The Jikei University Daisan Hospital)
Keiko Fukunaga, Kazuhiro Ikegame, Katsuji Kaida, Takayuki Inoue, Satoshi Yoshihara, Kyoko Yoshihara, Yuko Osugi, Hiroya Tamaki, Masaya Okada, Hiroyasu Ogawa, Yoshihiro Fujimori (Division of Hematology, Hyogo College of Medicine)
Shuki Oya, Yoshitaka Yamasaki, Takayuki Nakamura, Satoshi Morishige, Maki Yamaguchi, Kazutoshi Aoyama, Ritsuko Seki, Fumihiko Mouri, Koichi Osaki, Koji Nagafuji (Division of Hematology and Oncology, Department of Medicine, Kurume University)
Satoshi Nishiwaki1, Shuichi Mizuta2, Kazuteru Ohashi3, Takahiro Fukuda4, Naoyuki Uchida5, Heiwa Kanamori6, Makoto Onizuka7, Yukiyasu Ozawa8, Junji Tanaka9, Tatsuo Ichinohe10, Yoshiko Atsuta11, Shinichi Kako12 (1.Advanced Medicine, Nagoya Univ. Hospital, Nagoya, Japan, 2.Hematology & Immunology, Kanazawa Medical University, Kanazawa, Japan, 3.Hematology, Komagome Hospital, Tokyo, Japan, 4.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 5.Hematology, Toranomon Hospital, Tokyo, Japan, 6.Hematology, Kanagawa Cancer Center, Yokohama, Japan, 7.Hematology/Oncology, Tokai Univ., Isehara, Japan, 8.Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 9.Hematology, Tokyo Women's Medical Univ., Tokyo, Japan, 10.Hematology and Oncology, Hiroshima Univ., Hiroshima, Japan, 11.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 12.Hematology, Saitama Medical Center, Jichi Medical Univ., Saitama, Japan)
Maiko Abumiya1, Naoto Takahashi2, Takaya Yamashita2, Yongmei Guo2, Miho Nara2, Kumi Ubukawa2, Masumi Fujishima2, Naohito Fujishima2, Tomoko Yoshioka2, Yoshihiro Kameoka2, Masatomo Miura1 (1.Pharmacy, Akita Univ. Hospital, Akita, Japan, 2.Hematology, Nephrology and Rheumatology, Akita Univ., Akita, Japan)
Atsushi Watanabe1, Kunio Miyake2, Tamao Shinohara1, Yasushi Murakami1, Daisuke Harama1, Shinpei Somazu1, Koshi Akahane1, Kinuko Saito1, Yoshiyuki Furuichi1, Hiroki Sato1, Kazuya Takahashi1, Makoto Nakamura1, Satoru Kojika1, Kumiko Goi1, Masako Abe1, Keiko Kagami1, Hideo Yagita3, Kanji Sugita1, Takeshi Inukai1 (1.Dept. of Pediatr., Univ. of Yamanashi., Yamanashi, Japan, 2.Dept. of Health Sciences, Univ. of Yamanashi., Yamanashi, Japan, 3.Dept. of Immunol., Juntendo Univ., Tokyo, Japan)